These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38308915)

  • 1. Evaluating Relapse Knowledge in People with Multiple Sclerosis: A Cross-Sectional Study on the Development and Validation of the Relapse Knowledge Questionnaire.
    Wenzel L; Haker M; Heesen C; Kasper J; Köpke S; Rahn AC
    Mult Scler Relat Disord; 2024 Mar; 83():105381. PubMed ID: 38308915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knowledge and worries on motherhood choice in multiple sclerosis - a cross-sectional study on patient-reported outcome measures.
    Peper J; Köpke S; Solari A; Giordano A; Gold SM; Hellwig K; Steinberg L; Steckelberg A; Heesen C; Rahn AC
    Mult Scler Relat Disord; 2023 Aug; 76():104789. PubMed ID: 37327598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit evaluation in multiple sclerosis relapse treatment from the patients' perspective - Development and validation of a new questionnaire.
    Beckmann H; Augustin M; Heesen C; Poettgen J; Blome C
    Mult Scler Relat Disord; 2019 Feb; 28():256-261. PubMed ID: 30639826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Information provision for people with multiple sclerosis.
    Köpke S; Solari A; Rahn A; Khan F; Heesen C; Giordano A
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD008757. PubMed ID: 30317542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Knowledge in Relapsing Multiple Sclerosis (RIKNO 1.0)--Development of an Outcome Instrument for Educational Interventions.
    Heesen C; Kasper J; Fischer K; Köpke S; Rahn A; Backhus I; Poettgen J; Vahter L; Drulovic J; Van Nunen A; Beckmann Y; Liethmann K; Giordano A; Fulcher G; Solari A;
    PLoS One; 2015; 10(10):e0138364. PubMed ID: 26430887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decision-making about corticosteroids in relapses of multiple sclerosis - development of a questionnaire based on the theory of planned behaviour.
    Haker M; Heesen C; Wenzel L; Köpke S; Rahn AC; Kasper J
    Mult Scler Relat Disord; 2021 Oct; 55():103182. PubMed ID: 34358850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What should a person with relapsing-remitting multiple sclerosis know? - Focus group and survey data of a risk knowledge questionnaire (RIKNO 2.0).
    Heesen C; Pöttgen J; Rahn AC; Liethmann K; Kasper J; Vahter L; Drulovic J; Van Nunen A; Wilkie D; Beckmann Y; Paul F; Köpke S; Giordano A; Solari A;
    Mult Scler Relat Disord; 2017 Nov; 18():186-195. PubMed ID: 29141808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and psychometric properties of a self-assessed knowledge questionnaire for caregivers of people with multiple sclerosis (CareKoMS): a cross-sectional study.
    Podda J; Tacchino A; Verri A; Battaglia MA; Brichetto G; Ponzio M
    BMJ Open; 2023 Jun; 13(6):e071657. PubMed ID: 37399437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation of an interactive web-based decision-making programme on relapse management for people with multiple sclerosis (POWER@MS2)-study protocol for a randomised controlled trial.
    Rahn AC; Wenzel L; Icks A; Stahmann A; Scheiderbauer J; Grentzenberg K; Vomhof M; Montalbo J; Friede T; Heesen C; Köpke S
    Trials; 2021 Feb; 22(1):139. PubMed ID: 33583424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of the FSIQ-RMS: A New Patient-Reported Questionnaire to Assess Symptoms and Impacts of Fatigue in Relapsing Multiple Sclerosis.
    Hudgens S; Schüler R; Stokes J; Eremenco S; Hunsche E; Leist TP
    Value Health; 2019 Apr; 22(4):453-466. PubMed ID: 30975397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and usability testing of a patient decision aid for newly diagnosed relapsing multiple sclerosis patients.
    Bansback N; Chiu JA; Carruthers R; Metcalfe R; Lapointe E; Schabas A; Lenzen M; Lynd LD; Traboulsee A
    BMC Neurol; 2019 Jul; 19(1):173. PubMed ID: 31325961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric properties of the SDM-Q-9 questionnaire for shared decision-making in multiple sclerosis: item response theory modelling and confirmatory factor analysis.
    Ballesteros J; Moral E; Brieva L; Ruiz-Beato E; Prefasi D; Maurino J
    Health Qual Life Outcomes; 2017 Apr; 15(1):79. PubMed ID: 28431587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relapse prevalence, symptoms, and health care engagement: patient insights from the Multiple Sclerosis in America 2017 survey.
    Nazareth TA; Rava AR; Polyakov JL; Banfe EN; Waltrip Ii RW; Zerkowski KB; Herbert LB
    Mult Scler Relat Disord; 2018 Nov; 26():219-234. PubMed ID: 30368080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Information provision for people with multiple sclerosis.
    Köpke S; Solari A; Khan F; Heesen C; Giordano A
    Cochrane Database Syst Rev; 2014 Apr; (4):CD008757. PubMed ID: 24752330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Framework for personalized prediction of treatment response in relapsing remitting multiple sclerosis.
    Stühler E; Braune S; Lionetto F; Heer Y; Jules E; Westermann C; Bergmann A; van Hövell P;
    BMC Med Res Methodol; 2020 Feb; 20(1):24. PubMed ID: 32028898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and diagnosis of Secondary Progressive Multiple Sclerosis during the clinical encounter: Results from a physician survey.
    Alvarez E; Nair KV; Gorritz M; Bartolome L; Maloney H; Ding Y; Golan T; Wade RL; Kumar R; Su W; Shah R; Russo P
    Mult Scler Relat Disord; 2021 May; 50():102858. PubMed ID: 33799068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychometrics of the Multiple Sclerosis and Magnetic Resonance Imaging Knowledge Patient Questionnaire: A Pilot Study.
    Ben-Zacharia AB; Blessing O; Eckardt PA
    J Neurosci Nurs; 2022 Aug; 54(4):171-176. PubMed ID: 35687725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence and utility of screening for urinary tract infection at the time of presumed multiple sclerosis relapse.
    Fitzgerald KC; Cassard LA; Fox SR; Probasco JC; Cassard SD; Mowry EM
    Mult Scler Relat Disord; 2019 Oct; 35():61-66. PubMed ID: 31344604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability and validity of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis (Greek version) and proposed modification.
    Printza A; Kalaitzi M; Bakirtzis C; Nikolaidis I; Proios H; Grigoriadis N
    Mult Scler Relat Disord; 2018 Jul; 23():62-68. PubMed ID: 29778042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatigue during multiple sclerosis relapse and its relationship to depression and neurological disability.
    Šabanagić-Hajrić S; Suljić E; Kučukalić A
    Psychiatr Danub; 2015 Dec; 27(4):406-12. PubMed ID: 26609654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.